Researchers are exploring the use of CRISPR technology to enhance cancer immunotherapy, including its potential to optimize CAR T-cell therapy. The technology is being studied for its ability to improve the efficacy, safety, and accessibility of cancer treatments, with some research focusing on specific types of cancer, such as breast cancer. The use of CRISPR in cancer research and treatment is an area of ongoing investigation, with multiple studies and approaches underway to understand its potential benefits and limitations.